Therapeutic challenges and management of heart failure during pregnancy (part I)

Medical Science Monitor

Volumn 18, Issue 5, 2012, Pages

  Kryczka, Karolina ^a   Dzielińska, Zofia ^a   Przybylski, Andrzej ^a   Szczudlik, Julia ^b   Dangel, Joanna ^b   Konka, Marek ^a   Czajkowski, Krzysztof ^b   Rózański, Jacek ^a   Bilińska, Zofia T ^a   Demkow, Marcin ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Dilated cardiomyopathy; Heart failure; Heart failure treatment in pregnancy; Pregnancy

Indexed keywords

DIGITALIS; DIHYDRALAZINE; ENALAPRIL; FUROSEMIDE; ISOSORBIDE MONONITRATE; METOPROLOL; SPIRONOLACTONE;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR RISK; CASE REPORT; CESAREAN SECTION; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE EXACERBATION; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FETUS ECHOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; MITRAL VALVE REGURGITATION; OUTCOME ASSESSMENT; PERIPARTUM CARDIOMYOPATHY; PHYSICAL EXAMINATION; PREGNANCY COMPLICATION; PRIMARY PREVENTION; PULMONARY HYPERTENSION; QRS COMPLEX; RISK ASSESSMENT; SINUS TACHYCARDIA; SUDDEN DEATH; TREATMENT DURATION;

EID: 84860661650     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882716     Document Type: Article

References (0)